Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 45,872 shares at $55.09 ($2.6M) on 2021-02-19, disclosed to the SEC on 2021-02-19.
Open-market sale of $2.6M KYMR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.39 | 7,550 | $441K | 17.0% |
| 2 | $58.39 | 7,550 | $441K | 17.0% |
| 3 | $55.94 | 6,499 | $364K | 14.0% |
| 4 | $55.94 | 6,499 | $364K | 14.0% |
| 5 | $55.09 | 8,887 | $490K | 18.9% |
| 6 | $55.09 | 8,887 |
| $490K |
| 18.9% |
| Total | $56.42 avg | 45,872 | $2.6M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |